The Association Between Chlorhexidine Bathing and Central Line-Associated Infections in Medical Intensive Care Units
1 other identifier
observational
6,930
1 country
1
Brief Summary
We conducted a retrospective observational cohort study assessing the relationship between regular bathing using 2% CHG wipes every other day and the occurrence of central line-associated infections (CLABSI) in patients within the medical intensive care unit (MICU).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 30, 2023
CompletedFirst Submitted
Initial submission to the registry
June 13, 2023
CompletedFirst Posted
Study publicly available on registry
June 27, 2023
CompletedJune 27, 2023
April 1, 2023
18 days
June 13, 2023
June 25, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
central line-associated bloodstream infections
the incidence rate of intensive care unit acquired central line-associated bloodstream infections
Will be surveyed retrospectively through the study period (January 2017 to June 2022)
multidrug-resistant organisms bacteremia
the incidence of CLABSIs with blood cultures positive for multidrug-resistant organisms
Will be surveyed retrospectively through the study period (January 2017 to June 2022)
Secondary Outcomes (4)
ICU length of stay
Will be surveyed retrospectively through the study period (January 2017 to June 2022)
hospital length of stay
Will be surveyed retrospectively through the study period (January 2017 to June 2022)
ICU mortality
Will be surveyed retrospectively through the study period (January 2017 to June 2022)
hospital mortality
Will be surveyed retrospectively through the study period (January 2017 to June 2022)
Study Arms (2)
chlorhexidine group
Patients were bathed one day involving the use of wipes soaked in a 2% chlorhexidine gluconate (CHG) solution and the next day using a towel soaked with water and soap during the MICU stays.
usual care group
Patients were bathed with towels soaked in water and soap on a daily basis during the MICU stays.
Interventions
The procedure involved pouring an entire bottle (200ml) of 2% CHG solution (PBF Biotech, Taipei, Taiwan) onto a pre-packed set of eight single-use cotton wipes before each bathing session. A minimum of six wipes were required to thoroughly cover the entire body, including the bilateral upper and lower extremities, front and back of the trunk, perineum, and buttocks.
Eligibility Criteria
Our study included all patients aged eighteen years and older who were admitted to the MICU between January 2017 and June 2022, without any exclusions based on specific disease characteristics.
You may qualify if:
- all patients who were admitted to the MICU between January 2017 and June 2022
You may not qualify if:
- patients aged under 18 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University Hospital
Taipei, 100, Taiwan
Study Officials
- PRINCIPAL INVESTIGATOR
Yi-Chen Lin
National Taiwan University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2023
First Posted
June 27, 2023
Study Start
April 12, 2023
Primary Completion
April 30, 2023
Study Completion
May 30, 2023
Last Updated
June 27, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share